CW August 2000
Volume 9Issue Number 8 August 2000 ISSN 10593802 Altered PTEN Gene: An Early Marker for Endometrial CancerUnopposed exposure to estrogens increases the risk of endometrial cancer. Loss of the tumor suppressor gene PTEN may be an early event in the initiation of the disease in such an environment. Thus, PTEN mutation can be used as an important marker in the early detection of endometrial cancer, including the precancerous stage.
Go to Previous Page Go to Next Page Source & Additional Reading G. L. Mutter et al., Journal of the National Cancer Institute, June 7, 2000. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW August 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
